Clinical trials are central to modern medicine, meticulously designed to evaluate the safety and efficacy of new drugs and treatments. However, the carefully controlled environment of a clinical trial ...

It is important for regulatory clinical trials for ulcerative colitis to acknowledge that concomitant exposure to common medications does not affect UC treatment efficacy or safety. Concomitant use of ...

Presurgical treatment for inferior vena cava tumor thrombus in patients with renal cell carcinoma: A scoping review. Univariate analysis of survival outcomes and clinical benefit.

Baseline characteristics of patients with PSMA-PET–positive and –negative disease with high-risk of biochemical recurrence (BCR) after radical prostatectomy (RP) in the ongoing phase 3 PRIMORDIUM ...

During anticancer therapy, patients with cancer are often prescribed medications to combat concomitant health conditions and ameliorate cancer-associated side effects. Despite emerging evidence that ...

We assessed whether concomitant use of CYP2D6-inhibiting drugs associates with increased risk of fall injuries after newly initiated therapy with beta-blockers. A case-crossover study design was ...

Immunomodulatory drug users were significantly less likely to discontinue pegloticase compared to non-users with no additional concerning lab or safety findings. Concomitant immunomodulatory drug use ...

To evaluate the weight loss outcomes of the large U.S. cohort of patients undergoing endoscopic sleeve gastroplasty (ESG) with or without concomitant anti-obesity (AOM) use. We performed a ...